221 related articles for article (PubMed ID: 33098688)
21. An O-GlcNAc transferase pathogenic variant linked to intellectual disability affects pluripotent stem cell self-renewal.
Omelková M; Fenger CD; Murray M; Hammer TB; Pravata VM; Bartual SG; Czajewski I; Bayat A; Ferenbach AT; Stavridis MP; van Aalten DMF
Dis Model Mech; 2023 Jun; 16(6):. PubMed ID: 37334838
[TBL] [Abstract][Full Text] [Related]
22. The O-GlcNAc Transferase Intellectual Disability Mutation L254F Distorts the TPR Helix.
Gundogdu M; Llabrés S; Gorelik A; Ferenbach AT; Zachariae U; van Aalten DMF
Cell Chem Biol; 2018 May; 25(5):513-518.e4. PubMed ID: 29606577
[TBL] [Abstract][Full Text] [Related]
23. Catalytic deficiency of O-GlcNAc transferase leads to X-linked intellectual disability.
Pravata VM; Muha V; Gundogdu M; Ferenbach AT; Kakade PS; Vandadi V; Wilmes AC; Borodkin VS; Joss S; Stavridis MP; van Aalten DMF
Proc Natl Acad Sci U S A; 2019 Jul; 116(30):14961-14970. PubMed ID: 31296563
[TBL] [Abstract][Full Text] [Related]
24. The Hexosamine Biosynthesis Pathway: Regulation and Function.
Paneque A; Fortus H; Zheng J; Werlen G; Jacinto E
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107691
[TBL] [Abstract][Full Text] [Related]
25. O-linked β-N-acetylglucosamine transferase directs cell proliferation in idiopathic pulmonary arterial hypertension.
Barnes JW; Tian L; Heresi GA; Farver CF; Asosingh K; Comhair SA; Aulak KS; Dweik RA
Circulation; 2015 Apr; 131(14):1260-8. PubMed ID: 25663381
[TBL] [Abstract][Full Text] [Related]
26. Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.
Ma Z; Vocadlo DJ; Vosseller K
J Biol Chem; 2013 May; 288(21):15121-30. PubMed ID: 23592772
[TBL] [Abstract][Full Text] [Related]
27. On a sugar high: Role of O-GlcNAcylation in cancer.
Le Minh G; Esquea EM; Young RG; Huang J; Reginato MJ
J Biol Chem; 2023 Nov; 299(11):105344. PubMed ID: 37838167
[TBL] [Abstract][Full Text] [Related]
28. Mutational analysis of the catalytic domain of O-linked N-acetylglucosaminyl transferase.
Lazarus BD; Roos MD; Hanover JA
J Biol Chem; 2005 Oct; 280(42):35537-44. PubMed ID: 16105839
[TBL] [Abstract][Full Text] [Related]
29. Enhanced transfer of a photocross-linking N-acetylglucosamine (GlcNAc) analog by an O-GlcNAc transferase mutant with converted substrate specificity.
Rodriguez AC; Yu SH; Li B; Zegzouti H; Kohler JJ
J Biol Chem; 2015 Sep; 290(37):22638-48. PubMed ID: 26240142
[TBL] [Abstract][Full Text] [Related]
30. O-GlcNAc elevation through activation of the hexosamine biosynthetic pathway enhances cancer cell chemoresistance.
Liu Y; Cao Y; Pan X; Shi M; Wu Q; Huang T; Jiang H; Li W; Zhang J
Cell Death Dis; 2018 May; 9(5):485. PubMed ID: 29706631
[TBL] [Abstract][Full Text] [Related]
31. Impact of protein O-GlcNAcylation on neural tube malformation in diabetic embryopathy.
Kim G; Cao L; Reece EA; Zhao Z
Sci Rep; 2017 Sep; 7(1):11107. PubMed ID: 28894244
[TBL] [Abstract][Full Text] [Related]
32. Hexosamine biosynthetic pathway and
Kim DY; Park J; Han IO
Am J Physiol Cell Physiol; 2023 Oct; 325(4):C981-C998. PubMed ID: 37602414
[TBL] [Abstract][Full Text] [Related]
33. Fueling the fire: emerging role of the hexosamine biosynthetic pathway in cancer.
Akella NM; Ciraku L; Reginato MJ
BMC Biol; 2019 Jul; 17(1):52. PubMed ID: 31272438
[TBL] [Abstract][Full Text] [Related]
34. Cardioprotective O-GlcNAc signaling is elevated in murine female hearts via enhanced O-GlcNAc transferase activity.
Narayanan B; Sinha P; Henry R; Reeves RA; Paolocci N; Kohr MJ; Zachara NE
J Biol Chem; 2023 Dec; 299(12):105447. PubMed ID: 37949223
[TBL] [Abstract][Full Text] [Related]
35. O-GlcNAcylation-inducing treatments inhibit estrogen receptor α expression and confer resistance to 4-OH-tamoxifen in human breast cancer-derived MCF-7 cells.
Kanwal S; Fardini Y; Pagesy P; N'tumba-Byn T; Pierre-Eugène C; Masson E; Hampe C; Issad T
PLoS One; 2013; 8(7):e69150. PubMed ID: 23935944
[TBL] [Abstract][Full Text] [Related]
36. Repeated sleep deprivation decreases the flux into hexosamine biosynthetic pathway/O-GlcNAc cycling and aggravates Alzheimer's disease neuropathology in adult zebrafish.
Park J; Kim DY; Hwang GS; Han IO
J Neuroinflammation; 2023 Nov; 20(1):257. PubMed ID: 37946213
[TBL] [Abstract][Full Text] [Related]
37. The O-GlcNAc cycling in neurodevelopment and associated diseases.
Wenzel DM; Olivier-Van Stichelen S
Biochem Soc Trans; 2022 Dec; 50(6):1693-1702. PubMed ID: 36383066
[TBL] [Abstract][Full Text] [Related]
38. The conserved threonine-rich region of the HCF-1
Kapuria V; Röhrig UF; Waridel P; Lammers F; Borodkin VS; van Aalten DMF; Zoete V; Herr W
J Biol Chem; 2018 Nov; 293(46):17754-17768. PubMed ID: 30224358
[No Abstract] [Full Text] [Related]
39. Cross regulation between mTOR signaling and O-GlcNAcylation.
Very N; Steenackers A; Dubuquoy C; Vermuse J; Dubuquoy L; Lefebvre T; El Yazidi-Belkoura I
J Bioenerg Biomembr; 2018 Jun; 50(3):213-222. PubMed ID: 29524020
[TBL] [Abstract][Full Text] [Related]
40. Silencing the Nucleocytoplasmic O-GlcNAc Transferase Reduces Proliferation, Adhesion, and Migration of Cancer and Fetal Human Colon Cell Lines.
Steenackers A; Olivier-Van Stichelen S; Baldini SF; Dehennaut V; Toillon RA; Le Bourhis X; El Yazidi-Belkoura I; Lefebvre T
Front Endocrinol (Lausanne); 2016; 7():46. PubMed ID: 27252680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
